Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

13.45
Delayed Data
As of 4:00pm ET
 -0.30 / -2.18%
Today’s Change
10.25
Today|||52-Week Range
41.00
-3.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash231.6M202.8M187.0M176.1M
 
 
 
 
 
Short Term Investment Cash-17.4M-28.8M-15.8M-10.9M
 
 
 
 
 
Cash & Short Term Investments231.6M202.8M187.0M176.1M
 
 
 
 
 
 
ReceivablesReceivables6.2M6.3M2.4M2.8M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses579.0K1.2M1.0M833.0K
 
 
 
 
 
Current Assets238.3M210.3M190.4M179.8M
 
 
 
 
 
 
Total AssetsOther Assets173.0K129.0K83.0K83.0K
 
 
 
 
 
Total Assets238.5M210.5M190.5M179.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable15.7M11.8M6.8M6.7M
 
 
 
 
 
Short Term Debt6.7M6.7M6.7M6.7M
 
 
 
 
 
Accrued Expenses2.3M3.5M1.3M877.0K
 
 
 
 
 
Other Current Liabilities2.9M4.6M1.4M1.0M
 
 
 
 
 
Other Liabilities29.5M23.7M15.8M15.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt8.7M7.0M5.3M3.7M
 
 
 
 
 
Total Liabilities55.2M47.7M38.1M36.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity183.3M162.8M152.4M143.6M
 
 
 
 
 
Total Shareholder Equity183.3M162.8M152.4M143.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding10.5M10.5M10.5M10.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.